These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3030963)

  • 21. Renal handling of technetium-99m DMSA in rats with proximal tubular dysfunction.
    Provoost AP; Van Aken M
    J Nucl Med; 1985 Sep; 26(9):1063-7. PubMed ID: 2993552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metastasis of hypernephroid carcinoma to the bones detected by 99mTc-dimercaptosuccinic acid].
    Smirnov IuN; Ivanov EV
    Med Radiol (Mosk); 1983 Jan; 28(1):76-7. PubMed ID: 6298556
    [No Abstract]   [Full Text] [Related]  

  • 23. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
    Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
    Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
    Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
    J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA.
    Djokić D; Janković D; Nikolić N
    Cancer Biother Radiopharm; 2009 Feb; 24(1):129-36. PubMed ID: 19243255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
    Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
    Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
    Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
    J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
    Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
    Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.
    Miyauchi A; Endo K; Ohta H; Torizuka K; Matsuzuka F; Kobayashi A; Kuma K; Maeda M
    World J Surg; 1986 Aug; 10(4):640-5. PubMed ID: 3019022
    [No Abstract]   [Full Text] [Related]  

  • 30. Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors.
    Yee CA; Lee HB; Blaufox MD
    J Nucl Med; 1981 Dec; 22(12):1054-8. PubMed ID: 6273511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A kinetic model for 99mTc-DMSA in the rat.
    Maneval DC; D'Argenio DZ; Wolf W
    Eur J Nucl Med; 1990; 16(1):29-34. PubMed ID: 2155115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of 99Tcm (V) DMSA.
    Sampson CB
    Nucl Med Commun; 1987 Mar; 8(3):184-5. PubMed ID: 3035444
    [No Abstract]   [Full Text] [Related]  

  • 33. 2,3-Dimercaptosuccinic-acid chelates--1. Structure and pharmacokinetic studies.
    Moretti JL; Rapin JR; Saccavini JC; Lageron A; Le Poncin M; Bardy A
    Int J Nucl Med Biol; 1984; 11(3-4):270-4. PubMed ID: 6099340
    [No Abstract]   [Full Text] [Related]  

  • 34. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent.
    Babbar A; Kashyap R; Chauhan UP
    J Nucl Biol Med (1991); 1991; 35(2):100-4. PubMed ID: 1657203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two routes for 99mTc-DMSA uptake into the renal cortical tubular cell.
    Peters AM; Jones DH; Evans K; Gordon I
    Eur J Nucl Med; 1988; 14(11):555-61. PubMed ID: 2850186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
    Hirano T; Tomiyoshi K; Zhang YJ; Ishida T; Inoue T; Endo K
    Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of 99mTc-dimercaptosuccinic acid renal uptake as an index of individual kidney function after acute ureteral obstruction and desobstruction. An experimental study in rats.
    Schelfhout W; Simons M; Oosterlinck W; De Sy WA
    Eur Urol; 1983; 9(4):221-6. PubMed ID: 6307703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
    Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
    Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.